XTL Biopharmaceuticals Ltd.

(NASDAQ:XTLB; Tel Aviv:XTL)

Collapse Summary General Information
 Location Raanana, Israel
 Region
 Country Israel
 Business Category Autoimmune, Cancer
 Year Founded 1993
 Website http://www.xtlbio.com
 Lead Product Status Phase II
Get a free BioCentury trial today
 Archive Items are loading loading
 Financial Information
 
 Earnings Summary
 Stocks Annual Chart
Week of 11/17/2017 - 6,115,572 Week of 11/10/2017 - 3,793,727 Week of 11/03/2017 - 6,615,072 Week of 10/20/2017 - 4,714,724 Week of 10/13/2017 - 4,376,246 Week of 09/29/2017 - 3,166,232 Week of 09/15/2017 - 2,805,580 Week of 09/08/2017 - 3,141,723 Week of 08/25/2017 - 9,613,323 Week of 08/18/2017 - 10,439,770 Week of 08/11/2017 - 6,842,948 Week of 07/28/2017 - 4,832,890 Week of 07/21/2017 - 12,375,339 Week of 07/14/2017 - 11,881,884 Week of 07/07/2017 - 15,969,314 Week of 06/30/2017 - 13,496,589 Week of 06/23/2017 - 14,797,280 Week of 06/16/2017 - 12,525,840 Week of 06/09/2017 - 3,030,112 Week of 05/26/2017 - 7,164,048 Week of 05/19/2017 - 9,119,335 Week of 05/12/2017 - 9,341,594 Week of 05/05/2017 - 3,663,497 Week of 04/28/2017 - 11,235,352 Week of 04/21/2017 - 27,444,695 Week of 04/14/2017 - 13,113,219 Week of 04/07/2017 - 68,342,636 Week of 03/31/2017 - 26,926,593 Week of 03/24/2017 - 9,664,623 Week of 03/17/2017 - 45,880,708 Week of 03/10/2017 - 251,993,591 Week of 03/03/2017 - 75,993,173 Week of 02/24/2017 - 69,566,408 Week of 02/17/2017 - 338,237,609
 Pipeline Information
 
 Deals Information